Compare NMR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMR | STE |
|---|---|---|
| Founded | 1925 | 1985 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8B | 25.9B |
| IPO Year | 1961 | 1992 |
| Metric | NMR | STE |
|---|---|---|
| Price | $9.31 | $245.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $268.71 |
| AVG Volume (30 Days) | ★ 1.5M | 736.3K |
| Earning Date | 01-30-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.60% | 1.00% |
| EPS Growth | 11.88 | ★ 51.78 |
| EPS | 0.75 | ★ 7.16 |
| Revenue | ★ $13,032,036,613.00 | $5,828,015,000.00 |
| Revenue This Year | $2.08 | $9.61 |
| Revenue Next Year | N/A | $6.23 |
| P/E Ratio | ★ $11.49 | $35.21 |
| Revenue Growth | ★ 8.40 | 7.96 |
| 52 Week Low | $4.86 | $204.90 |
| 52 Week High | $9.47 | $269.44 |
| Indicator | NMR | STE |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 39.33 |
| Support Level | $8.58 | $226.41 |
| Resistance Level | $8.92 | $252.98 |
| Average True Range (ATR) | 0.18 | 6.63 |
| MACD | -0.03 | -1.86 |
| Stochastic Oscillator | 85.92 | 48.44 |
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking, which is engaged in advisory, financing, and solutions businesses.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.